ArticleCancers2022

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome.

Maddalena Marconato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.